Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ovarian PRP for Diminished Ovarian Reserve
Sponsor: Generation Next Fertility
Summary
This prospective double-blinded randomized placebo control study aims to determine if In Vitro Fertilization (IVF) outcomes are improved by ovarian platelet-rich plasma injections (oPRP) for women diagnosed with diminished ovarian reserve (DOR). Women with DOR notoriously have the lowest chance of pregnancy and live birth compared to age-matched peers with a normal or robust ovarian reserve.
Official title: Ovarian Platelet-Rich Plasma Injections for Diminished Ovarian Reserve Patients: A Double-Blinded Placebo-Control Trial
Key Details
Gender
FEMALE
Age Range
35 Years - 42 Years
Study Type
INTERVENTIONAL
Enrollment
230
Start Date
2023-10-07
Completion Date
2025-12-31
Last Updated
2025-02-13
Healthy Volunteers
Yes
Conditions
Interventions
oPRP
Prepared sample from patient's own blood collected and processed. Either PRP or serum is injected into the patient's ovary. All other care is standard for the IVF process
Placebo- Serum
Patient's serum is injected into ovary instead of PRP as placebo
Locations (1)
Generation Next Fertility
New York, New York, United States